Novonesis (Novozymes) A/S B
Novonesis (Novozymes) A/S B/ DK0060336014 /
NSIS/B
13/05/2024 00:00:00
|
Chg.
+1.10
|
Volume |
Bid17:10:00 |
Ask17:10:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
419.50DKK
|
+0.26%
|
678,614 Turnover: 271.88 mill. |
419.00Bid Size: - |
419.60Ask Size: - |
117.37 bill.DKK |
1.42% |
31.69 |
Fundamentals
|
FY 2022 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
13.29 DKK |
17.40% |
EPS Diluted: |
- DKK |
17.45% |
Revenues per Share: |
62.97 DKK |
-3.86% |
Book Value per Share: |
49.64 DKK |
-4.19% |
Cash Flow per Share: |
14.37 DKK |
-19.24% |
Dividend per Share: |
6.00 DKK |
9.09% |
Total |
in mill. |
|
Revenues: |
17,553.00 DKK |
17.40% |
Net Income: |
3,686.00 DKK |
17.20% |
Operating Cash Flow: |
4,006.00 DKK |
- |
Cash and Cash Equivalents: |
1,041.00 DKK |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
31.69 |
26.48 |
P/S Ratio: |
6.69 |
5.59 |
P/BV ratio: |
8.48 |
7.09 |
P/CF Ratio: |
29.30 |
24.48 |
PEG: |
1.82 |
1.52 |
Earnings Yield: |
3.16% |
3.78% |
Dividend Yield: |
1.42% |
1.71% |
Market Capitalization |
|
Market Capitalization: |
117.37 bill. DKK |
98.09 bill. DKK |
Free Float Market Cap.: |
- DKK |
- DKK |
Market Cap. / Employee: |
17.31 mill. DKK |
14.46 mill. DKK |
Shares Outstanding: |
278.73 mill. |
|
Profitability
Gross Profit Margin: |
54.56% |
EBIT Margin: |
25.98% |
Net Profit Margin: |
21.00% |
Return on Equity: |
26.64% |
Return on Assets: |
13.17% |
Financial Strength
Liquidity I / Cash Ratio: |
14.95% |
Liquidity II / Quick Ratio: |
64.56% |
Liquidity III / Current Ratio: |
132.72% |
Debt / Equity Ratio: |
102.23% |
Dynam. Debt / Equity Ratio: |
353.12% |
Efficiency
Employees: |
6,781 |
Personal Expenses / Employee: |
- DKK |
Revenues / Employee: |
2,588,556.26 DKK |
Net Income / Employee: |
543,577.64 DKK |
Total Assets / Employee: |
4,126,677.48 DKK |
* Fiscal Year End: |
31/12/2022 |
Accounting Standard: |
IFRS |